Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells

被引:32
作者
Bretz, JD
Mezosi, E
Giordano, TJ
Gauger, PG
Thompson, NW
Baker, JR
机构
[1] Univ Michigan, Med Ctr, Ctr Biol Nanotechnol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Ctr, Dept Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Med Ctr, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA
关键词
apoptosis; autoimmune disease; death receptor 5; decoy receptor; inflammatory cytokine; interferon gamma;
D O I
10.1038/sj.cdd.4400965
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Death receptor-mediated apoptosis has been implicated in target organ destruction in chronic autoimmune thyroiditis. Depending on the circumstances, inflammatory cytokines such as IL-1, TNF and IFNgamma have been shown to contribute to either the induction, progression or inhibition of this disease. Here we demonstrate that the death ligand TRAIL can induce apoptosis in primary, normal, thyroid epithelial cells under physiologically relevant conditions, specifically, treatment with the combination of inflammatory cytokines IL-1beta and TNFalpha. In contrast, IFNgamma is capable of blocking TRAIL-induced apoptosis in these cells. This regulation of TRAIL-mediated apoptosis by inflammatory cytokines appears to be due to alterations of cell surface expression of TRAIL receptor DR5 and not DR4. We also show the in vivo presence of TRAIL and TRAIL receptors DR5 and DcR1 in both normal and inflamed thyroids. Our data suggests TRAIL-mediated apoptosis may contribute to target organ destruction in chronic autoimmune thyroiditis.
引用
收藏
页码:274 / 286
页数:13
相关论文
共 56 条
[41]   Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis [J].
Ohsako, S ;
Elkon, KB .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (01) :13-21
[42]  
Pai SI, 1998, CANCER RES, V58, P3513
[43]   An antagonist decoy receptor and a death domain-containing receptor for TRAIL [J].
Pan, GH ;
Ni, J ;
Wei, YF ;
Yu, GL ;
Gentz, R ;
Dixit, VM .
SCIENCE, 1997, 277 (5327) :815-818
[44]   Possible pathogenetic relevance of interleukin-1β in "'destructive" organ-specific autoimmune disease (Hashimoto's thyroiditis) [J].
Paolieri, F ;
Salmaso, C ;
Battifora, M ;
Montagna, P ;
Pesce, G ;
Bagnasco, M ;
Richiusa, P ;
Galluzzo, A ;
Giordano, C .
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES, 1999, 876 :221-228
[45]  
Rudin CM, 1997, ANNU REV MED, V48, P267
[46]   Apoptosis signaling in lymphocytes [J].
Scaffidi, C ;
Kirchhoff, S ;
Krammer, PH ;
Peter, ME .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (03) :277-285
[47]   Iodide, cytokines and TSH-receptor expression in Graves' disease [J].
Schuppert, F ;
Hiller, W ;
Weinland, G ;
HoangVu, C ;
vonzurMuhlen, A ;
Kohn, LD .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 :68-74
[48]   Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression [J].
Song, KM ;
Chen, YG ;
Göke, R ;
Wilmen, A ;
Seidel, C ;
Göke, A ;
Hilliard, B ;
Chen, YH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (07) :1095-1103
[49]  
STULL SJ, 1992, J IMMUNOL, V149, P2219
[50]   Significant role for Fas in the pathogenesis of autoimmune diabetes [J].
Su, X ;
Hu, QL ;
Kristan, JM ;
Costa, C ;
Shen, YM ;
Gero, D ;
Matis, LA ;
Wang, Y .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2523-2532